User profiles for Francisco Ojeda

Francisco Ojeda

University Heart and Vascular Center UKE Hamburg, Germany
Verified email at uke.de
Cited by 7210

Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction

T Keller, T Zeller, F Ojeda, S Tzikas, L Lillpopp… - Jama, 2011 - jamanetwork.com
Context Introduction of highly sensitive troponin assays into clinical practice has substantially
improved the evaluation of patients with chest pain. Objective To evaluate the diagnostic …

Copeptin improves early diagnosis of acute myocardial infarction

…, S Tzikas, T Zeller, E Czyz, L Lillpopp, FM Ojeda… - Journal of the American …, 2010 - jacc.org
Objectives : Early identification of myocardial infarction in chest pain patients is crucial to
identify patients at risk and to maintain a fast treatment initiation. Background : The aim of the …

Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker …

C Magnussen, TJ Niiranen, FM Ojeda, F Gianfagna… - Circulation, 2017 - Am Heart Assoc
Background: Atrial fibrillation (AF) is a common cardiac disease in aging populations with
high comorbidity and mortality. Sex differences in AF epidemiology are insufficiently …

[HTML][HTML] Application of high-sensitivity troponin in suspected myocardial infarction

JT Neumann, R Twerenbold, F Ojeda… - … England Journal of …, 2019 - Mass Medical Soc
Background Data regarding high-sensitivity troponin concentrations in patients presenting
to the emergency department with symptoms suggestive of myocardial infarction may be …

Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium

…, V Salomaa, N Makarova, F Ojeda… - European heart …, 2016 - academic.oup.com
Aims Our aims were to evaluate the distribution of troponin I concentrations in population
cohorts across Europe, to characterize the association with cardiovascular outcomes, to …

[HTML][HTML] Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

FJ Brunner, C Waldeyer, F Ojeda, V Salomaa, F Kee… - The lancet, 2019 - thelancet.com
Background The relevance of blood lipid concentrations to long-term incidence of
cardiovascular disease and the relevance of lipid-lowering therapy for cardiovascular disease …

Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm

…, NA Sörensen, T Schwemer, F Ojeda… - JAMA …, 2016 - jamanetwork.com
Importance Rapid and accurate diagnosis of acute myocardial infarction (AMI) currently
constitutes an unmet need. Objective To test a 1-hour diagnostic algorithm to diagnose AMI …

Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease—results from the large AtheroGene study

…, C Schulte, S Appelbaum, F Ojeda… - European heart …, 2017 - academic.oup.com
Introduction Stratification for subsequent coronary events among patients with coronary
artery disease (CAD) is of considerable interest because of the potential to guide secondary …

[HTML][HTML] miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease

C Schulte, S Molz, S Appelbaum, M Karakas, F Ojeda… - PloS one, 2015 - journals.plos.org
Background Circulating microRNAs (miRNAs) have been described as potential diagnostic
biomarkers in cardiovascular disease and in particular, coronary artery disease (CAD). Few …

Lipoprotein (a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

…, B Thorand, F Kee, W Koenig, F Ojeda… - European heart …, 2017 - academic.oup.com
Aims As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a
precise characterization and comparability of the Lp(a)-associated cardiovascular risk is …